Click here for slides on this topic


Insulin resistance

Reduced effectiveness of insulin to mediate its metabolic effects. Insulin resistance generally refers to glucose metabolism, but can be used to describe reductions in other aspects of insulin action. Insulin resistance is a primary abnormality that places people at risk for type 2 diabetes. Additional conditions may be associated with insulin resistance, including cardiovascular disease, hyperinsulinemia, dyslipidemia, hypertension, abdominal obesity, and clotting abnormalities, among others.


The following content matched the glossary term: Insulin resistance

Supporting a Family Member or Friend With Type 2 Diabetes

Top

Patient education handout that provides tips for offering support to a family member, friend, or loved one with type 2 diabetes.

Managing the Patient With Type 2 Diabetes and Heart Failure

Top

.style1 FONT FAMILY Arial, Helvetica, sans serif COLOR #004685

T195-04

Top

Patient education handout exploring the connection between diabetes and cardiovascular disease.

T195-03

Top

Patient education handout describing what causes type 2 diabetes; the effects of diabetes on patient quality of life; and diabetes treatments.

Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease

Top

De Felice FG, Ferreira ST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes. 2014. DOI:10.2337/db13-1954.

Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin + MDI insulin

Top

Rosenstock J, Jelaska A, Frappin G, et al; on behalf of the EMPA-REG MDI Trial Investigators. Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. Diabetes Care. 2014. DOI:10.2337/dc13-3055.

American Diabetes Association (ADA)/American Geriatrics Society (AGS) Guidelines 2012

Top

Diabetes management guidelines for older adults from the American Diabetes Association (ADA)/American Geriatrics Society (AGS) 

Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults

Top

Neeland IJ, Turer AT, Ayers CR, Powell Wiley TM, Vega GL, Farzaneh Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308(11):1150-1159. The risk of type 2 diabetes mellitus is heterogeneous among obese individuals. Factors that discriminate prediabetes or diabetes risk within this population have not been well characterized.

Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity

Top

Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35:1420-1428. The authors of the current prospective study sought to examine the potential benefits of laparoscopic Roux-en-Y gastric bypass (LRYGB) among those with BMI 30-34.9 kg/m2 (class I obesity) and type 2 diabetes.

NDEI.org Expert Commentary on EUREXA Trial Burton Sobel, MD

Top

NDEI.org expert commentary on European Exenatide (EUREXA) trial from Burton Sobel, MD

1 2 3 4 5 6 7 8 9 10  ... Next 

Slide Library Results

Search Results for: Insulin resistance Slides Found: 72
Insulin Resistance: Definitions
Insulin Resistance: Inherited and Acquired Influences
Ethnicity vs Race
Prevalence of the Insulin Resistance Syndrome (NCEP) in the US Population
Family History of Diabetes and Risk for Insulin Resistance in Mexican Amercians
Risk Factors for Conversion to Diabetes in Mexican Americans
Association Between Insulin Sensitivity and Physical Exercise The IRAS Study
Treating Insulin Resistance Reduces Incidence of Type 2 Diabetes
Treating Insulin Resistance Preserves b-Cell Function
Hypertension and Glucose Tolerance in Four Ethnic Groups
Opportunities and Challenges for Care Extended Family Roles
Addressing Sociocultural Issues
Type 2 Diabetes Prevention Studies
Energy Balance: Intake vs Expenditure
Increased Fructose Consumption and the Rise in Obesity
Assessing Risk for Morbidity and Mortality: Comorbidities and Other Risk Factors
Effect of Aerobic Exercise on Insulin Resistance
Relationship Between Flow-Mediated Brachial Artery Dilation and Weight Loss After Lifestyle Modification
Changes in Flow-Mediated Brachial Artery Dilation After 6 Months of Lifestyle Modification
Effect of Diet and Exercise on Adipokines
Effect of Diet and Exercise on Inflammatory Markers
Effect of Sibutramine, Orlistat, and Metformin on Risk Factors for Type 2 Diabetes
Effect of Bariatric Surgery on Acute Insulin Response
Insulin Resistance: Definitions
Association Between Small, Dense LDL and Insulin Resistance
Insulin Resistance: Inherited and Acquired Influences
Effect of Pioglitazone on Insulin Resistance: HOMA-IR
Effect of Early Thiazolidinedione Therapy on A1C Levels
Effect of Early Thiazolidinedione Therapy on C-Peptide Levels
Effect of Early Thiazolidinedione Therapy on Diabetes Onset
IRAS: Number of CVD Risk Factors and Conversion to Type 2 Diabetes
Gender Differences Influence Impact of Type 2 Diabetes on CHD Risk
CARDIA: Fast-Food Frequency and Insulin Resistance
Pioglitazone Decreases Carotid IMT Independent of Glycemic Control in Patients With Type 2 Diabetes
Prevalence of IFG in Nondiabetic US Adolescents (Aged 12–19 Yrs)
Waist Circumference, TG Levels Predict Future MetS in 18- to 19-Yr-Old Females
Comparison of Diabetes Rates Across PIPOD and TRIPOD
Beta-Cell Adaptation to Insulin Resistance: Longitudinal Data in Normal Women
Plasticity of Islets: Experimental Increase in Beta-Cell Mass in Response to IR
Neogenesis May Contribute to Increased Islet Mass in Obese Humans
Hypothetical Relationships Determine Categories of Glucose Tolerance
Type 2 Diabetes: Pathogenesis in a Nutshell
Type 2 Diabetes: Pathogenesis in a Nutshell (cont.)
Decreased beta-Cell Function in Groups With Diabetes and at High Risk
Short-term beta-Cell Adaptation: Response to Pregnancy
Loss of beta-Cell Function in People Who Develop Type 2 Diabetes: Longitudinal Data
Tools to Assess beta-Cell Health and Function
Effect of Sitagliptin + Metformin on FPG in Patients with Type 2 Diabetes
IRAS: CVD Risk Factors Are Also Risk Factors for Type 2 Diabetes
Pioglitazone Reduces the Risk of Hospitalization for AMI
IRAS: Risk of Type 2 Diabetes Based on Food-Pattern Score at Baseline
IRAS: Risk of Type 2 Diabetes by Food-Pattern Score and Obesity Status
Impact of Higher Heart Rate on Development of Cardiometabolic Risk Factors After 20 Years
DPPOS Substudy: NGR Predictors During DPPOS
Health Consequences of Obesity
Roux-en-Y Gastric Bypass Surgery in Type 2 Diabetes and Mild Obesity: Glycemic Control Results
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Key Facts on Prevalence, Epidemiology
Diabetes Cognitive Dysfunction | NDEI
Type 2 Diabetes Alzheimer Disease | NDEI
Type 2 Diabetes Treatments Used for Alzheimer Disease? | NDEI
Safety Bariatric Surgery for BMI <35 at 1 Year
JUPITER Secondary Analysis Assesses Statin Use & Diabetes Risk | NDEI
JUPITER High-Intensity Rosuvastatin & Lipoprotein Particles | NDEI
JUPITER Effect of High-Intensity Rosuvastatin on Lipoproteins Diabetes | NDEI
JUPITER Rosuvastatin & Incident Type 2 Diabetes | NDEI
JUPITER Insulin Resistance Associated With Risk Factors | NDEI
JUPITER Incident Diabetes Associated With More Risk Factors Rosuvastatin | NDEI
NLA Cholesterol Guidelines Metabolic Syndrome Criteria | CCMD
IRIS Design Pioglitazone Effect on Cerebrovascular Disease Stroke PPT | NDEI
IRIS Pioglitazone Lowers Risk for Stroke and TIA Vs Placebo PPT | NDEI
IRIS Pioglitazone Lowers Rate of Progression to Diabetes Vs Placebo | NDEI
IRIS Safety of Pioglitazone Vs Placebo After Stroke or TIA PPT | NDEI